Detalhe da pesquisa
1.
Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.
Breast Cancer Res
; 25(1): 57, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226243
2.
Association of breast cancer risk, density, and stiffness: global tissue stiffness on breast MR elastography (MRE).
Breast Cancer Res Treat
; 194(1): 79-89, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501423
3.
Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase.
Breast Cancer Res Treat
; 185(3): 759-771, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201358
4.
Causes of death after breast cancer diagnosis: A US population-based analysis.
Cancer
; 126(7): 1559-1567, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840240
5.
N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer.
Breast Cancer Res Treat
; 182(3): 613-622, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504284
6.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
7.
Understanding American Indian Perceptions Toward Radiation Therapy.
Cancer Control
; 27(3): 1073274820945991, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735143
8.
Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease.
J Surg Oncol
; 122(4): 619-622, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506815
9.
Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival.
Support Care Cancer
; 28(5): 2139-2143, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402403
10.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
11.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
12.
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Ann Surg Oncol
; 25(5): 1350-1356, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29516362
13.
The Future of Contrast-Enhanced Mammography.
AJR Am J Roentgenol
; 210(2): 292-300, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29064748
14.
Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy.
Breast J
; 24(6): 1010-1014, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30066421
15.
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.
Breast Cancer Res
; 19(1): 123, 2017 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29162134
16.
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Breast Cancer Res
; 19(1): 130, 2017 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212525
17.
Survival benefit needed to undergo chemotherapy: Patient and physician preferences.
Cancer
; 123(15): 2821-2828, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28323331
18.
Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy?
Breast Cancer Res Treat
; 165(3): 545-553, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28646344
19.
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Breast Cancer Res Treat
; 164(1): 189-199, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429243
20.
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
Am J Hematol
; 92(5): 448-453, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28211162